N/A N=63 Randomized Double-blind Treatment

Ultrasound Guided Knee Injections in Musculoskeletal Medicine

Knee Osteoarthritis

Bottom Line

View on ClinicalTrials.gov: NCT03293238 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2019

Primary outcome: Primary: Number of Participants With Successful Knee Injection — 17; 14; 13; 7 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Joint line ultrasound (Procedure); Joint line landmark (Procedure); Suprapatellar ultrasound guided (Procedure); Suprapatellar Landmark (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Andrews Research & Education Foundation
Primary completion: Feb 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Successful Knee Injection	17; 14; 13; 7	—
SECONDARY Procedural Satisfaction Score at 3 Months Post Injection	7.84; 8.71; 7.14; 8.29	0.527
SECONDARY Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score	48.05; 43.75; 53.15; 47.61; 23.42; 31.07	0.749

Summary

This study will compare the accuracy and patient reported outcomes between four different techniques used to perform a knee injection.

Eligibility Criteria

Inclusion Criteria

Male or female, age 18 to 90
Clinician determined need for intra-articular knee injection
Radiograph confirmed grade 1-4 Kellgren Lawrence osteoarthritis scale

Exclusion Criteria

Allergy to contrast dye, shellfish
Allergy to egg product or hyaluronate
Allergy to lidocaine
Localized skin infection at planned site of injection
Inability to complete follow-up phone call three months following the injection
Viscosupplementation injection within 6 months of the current evaluation

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03293238). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.